High-dose vitamin B3 (niacin) may boost immune function and slow glioblastoma progression, with 82% of trial patients showing ...

Cellular therapies that harness a patient’s own immune system to identify and eliminate cancer cells are rapidly expanding ...

ORIC Pharmaceuticals (ORIC) lost ~22% in extended trading after the company reported data from a Phase 1b trial for its prostate cancer therapy rinzimetostat (ORIC-944) developed in combination with ...

A novel technique for treating GBM first underwent a phase 1 clinical trial with patients who had recurrence of their cancers ...

A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage immunotherapy company developing first-in-class logic-gated therapies for ...

Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to ...

When patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and ...

The post HYD Pioneers New Research Revealing Systemic Role of Deuterium-Depleted Water in Cancer Therapy appeared first on ...

Like tiny superheroes, small, naturally occurring segments of RNA can block multiple molecular paths that cancer cells use to ...

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...

North Carolina and other states have insurance plans for kids in foster care, but many doctors did not accept patients on the ...